To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure email@example.com
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter presents the definition, epidemiology, diagnosis and principles of management for arteriovenous malformations (AVMs). The primary goal of AVM management is to assess the overall risk of the patient, and then develop a management plan that minimizes risks, i.e., deciding whether obliteration or observation is safest. The primary goal of obliterative AVM treatment by any modality is the prevention of hemorrhage. The epileptogenicity resulting from a hemorrhage and from hemosiderin deposition has been documented. Treatment of AVMs, with surgery, radiation, embolization, or a combination of these, can cause new seizures in some patients with AVMs, albeit with a risk which is much smaller than the risk of the AVM itself causing seizures. While the primary goal of AVM treatment is the prevention of hemorrhage, several retrospective series have also demonstrated a benefit in seizure outcome with AVM treatment with surgery, radiation, embolization, or multimodality treatment.
This report summarizes an invitational symposium on epilepsy and Canadian laws governing motor vehicle driving held in Québec City in November 1998.
Invited neurological experts from Canada, the USA, and Europe; and representatives of provincial and territorial licensing bodies, the Canadian Council of Motor Transport Administrators, the Canadian Medical Protective Association, and the Canadian Medical Association participated. An edited version of transcribed audiotapes was prepared. Specific issues discussed were whether or not a physician should be required to report a patient with epilepsy to the licensing authority (mandatory reporting), the nature and quantification of the risks posed by epileptic drivers, and what would be a reasonable law regulating driving by people with epilepsy in Canada.
The consensus among medical experts was that mandatory reporting should be abolished in Canada and that a 6-12 month seizure-free period was appropriate before most patients could return to driving private cars. Experts also believed that these standards should be uniform across Canada. There was strong disagreement with the recommendation of the Canadian Medical Association that all such drivers be reported to provincial licensing authorities even in provinces without mandatory reporting rules.
Physicians should be familiar with and follow the rules regarding epilepsy and driving in the provinces where they practice. Nevertheless, current evidence is against mandatory physician reporting of drivers with epilepsy and the neurologists recommended that this be abolished throughout Canada. Shorter seizure-free intervals should also be considered before resuming driving of private cars.
Email your librarian or administrator to recommend adding this to your organisation's collection.